Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer.
Solmaz AghaAmiriJo SimienAlastair M ThompsonJulie VossSukhen C GhoshServando Hernandez VargasSarah KimAli AzhdariniaHop S Tran CaoPublished in: Molecular imaging (2021)
We showed for the first time that fluorescent trastuzumab and pertuzumab immunoconjugates have similar NIRF imaging performance and demonstrated the possibility of performing HER2-targeted FGS with agents that possess distinct epitope specificity.